Pharmaceutical Supply Chain Intelligence
Analysis of global API ecosystems, biologics manufacturing expansion, capacity investment and international distribution strategy.
Supply stability and manufacturing scale are strategic determinants in rare disease and oncology drug accessibility.
Counterfeit PD-1 Drugs Are Increasing: How Can Patients Identify Legitimate Pharmaceutical Channels?
July 09, 2026
Why Do Primary Healthcare Facilities Frequently Experience Drug Supply Shortages? Strengthening the Pharmaceutical Supply Chain for Continuous Access to Medicines
July 02, 2026
Explore why primary healthcare facilities frequently experience medicine shortages and how resilient pharmaceutical supply chains, inventory management, digital technologies, and strategic distribution improve continuous access to essential medicines.
How DTP Pharmacies Are Transforming Innovative Drug Commercialization and Patient Access
July 01, 2026
From Drug Dispensing to Medication Management: How Can Pharmacies Build a Drug Interaction Alert System?
June 26, 2026
How Guideline Recommendation Levels (A/B/C) Can Guide Inventory Prioritization
June 24, 2026
How Can a Box of Medicine Travel Thousands of Miles? The Power Behind Pharmaceutical Logistics Coverage
June 16, 2026
Explore how pharmaceutical logistics networks, cold chain systems, digital supply chains, and global distribution infrastructure ensure medicines safely reach patients across continents.
When APIs Are Controlled by a Few Companies: How Risks Spread Across the Pharmaceutical Supply Chain
June 15, 2026
Explore how concentration in active pharmaceutical ingredient production creates supply chain risks that can spread from API manufacturers to pharmaceutical companies, hospitals, and patients worldwide.
Primary Healthcare Pharmaceutical Supply: Supply Security, Distribution Systems, and Primary Coverage
June 13, 2026
Explore the challenges and future development of pharmaceutical supply in primary healthcare, including supply security, drug distribution systems, cold-chain logistics, and long-term medication accessibility.
When a Drug Struggles in Big Cities but Becomes a Bestseller in Community Healthcare: What Medicine Distribution Reveals About Global Access to Medicines
June 09, 2026
Avoid Pitfalls in Overseas Medical Treatment: Beware of Unlicensed Medical Brokers and Protect Your Health and Finances
June 03, 2026
Learn how to identify unlicensed medical brokers, avoid overseas healthcare scams, verify international medical providers, and protect your health and finances when seeking treatment abroad.
Recommended Countries for Overseas Medical Treatment: Why More Patients Are Choosing Cost-Effective Healthcare in China
June 03, 2026
Counterfeit Cancer Drugs, Weight-Loss Medications, and ED Pills: The Growing Global Threat to Patient Safety
May 27, 2026
Counterfeit cancer drugs, fake PD-1 therapies, counterfeit GLP-1 weight-loss medications, and fake ED pills are creating growing risks for patient safety worldwide.
Lilly’s Triple Agonist Retatrutide Shows Promising Phase III Results: Up to 2% HbA1c Reduction and Nearly 17% Weight Loss
May 27, 2026
Eli Lilly’s Retatrutide demonstrated significant HbA1c reduction and weight-loss efficacy in Phase III diabetes trials, accelerating the transition toward the triple agonist era in metabolic disease treatment.
How AI Reshapes Drug R&D: A Full-Chain Innovation from Target Discovery to Clinical Trials
May 26, 2026
Artificial intelligence is reshaping pharmaceutical R&D from target discovery to clinical trial optimization, accelerating innovation across the entire drug development chain.
Eli Lilly’s Retatrutide Phase 3 Data Shocks the Market: Behind the 30% Weight Loss, the Peptide API Supply Chain Emerges as a New Hotspot
May 26, 2026
Eli Lilly’s Retatrutide Phase 3 data is reshaping the obesity drug market while accelerating global demand for peptide API manufacturing and supply chain capacity.
How Pharmaceutical Distributors Respond to Transportation Requirements for Different Dosage Forms
May 23, 2026
How pharmaceutical distributors manage transportation requirements for different dosage forms, including tablets, injectables, biologics, lyophilized drugs, and advanced therapies.
How Big Is the Difference Between Dosage Forms of the Same Drug?
May 19, 2026
Explore how different pharmaceutical dosage forms affect therapeutic outcomes, drug delivery, patient adherence, cold-chain logistics, and global pharmaceutical supply systems.
Metformin Immediate-Release, Enteric-Coated, and Extended-Release Tablets: Do They Have the Same Blood Sugar-Lowering Effect?
May 19, 2026
Learn the differences between immediate-release, enteric-coated, and extended-release metformin tablets, including blood sugar control, gastrointestinal side effects, convenience, and long-term diabetes management.
Oral Dissolving Films: A New Dosage Form Transforming the Modern Medication Experience
May 19, 2026
Explore how oral dissolving films (ODFs) are transforming modern medication delivery with improved convenience, faster absorption, and better patient experience.
Global Pharmaceutical Market Under Policy Influence: Reshaping the Landscape and Future Opportunities
May 07, 2026
How pharmaceutical policies are reshaping the global market, influencing innovation, pricing, compliance, and future opportunities in the healthcare industry.